Furthermore, the reductionist approach we employed in the current study to characterize unique characteristics of the anti-GRP78 IgG autoantibodies in COPD patients almost certainly underestimated the aggregate pathologic effects of these autoimmune responses in vivo. The gene discussed is HSPA5; the disease is chronic obstructive pulmonary disease.